VEGFA and retinal disorder: To evaluate the neutralization of mouse VEGF by aflibercept and ranibizumab in vivo, we first examined retinal vascular structural changes after intravitreal injection of aflibercept and ranibizumab in oxygen-induced-retinopathy (OIR) model mice (Fig 1, n = 7 /group).